High-throughput platforms can be used to develop tertiary phase diagrams, which can be leveraged to identify the most stable SEDDS formulations and excipients for lipid-based drug delivery systems.
Frank Romanski
Advertisement
Frank Romanski, PhD is head of Global Marketing, Pharma Solutions, BASF Corp, Florham Park, NJ, frank.romanski@basf.com.
Articles by Frank Romanski
Advertisement
Latest Updated Articles
How Excipient Type Influences Self-Emulsifying Drug DeliveryPublished: October 1st 2019 | Updated:
Advertisement
Advertisement
